通过蛋白质学寻找动脉样硬化生物标志物:关注损伤病原和脆弱性
Gabriele Nieddu1, Marilena Formato1, Antonio Junior Lepedda1
1Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
International journal of molecular sciences
|October 28, 2023
概括
蛋白质组学和体组学技术对于识别斑块破裂和血栓形成的早期生物标志物至关重要,有助于预防心血管和脑血管疾病. 本综述强调了过去二十年来脂蛋白组学和血管组织蛋白学方面的进展.
科学领域:
- 心血管科学 心血管科学
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
背景情况:
- 斑块破裂和血栓形成是中风和心血管疾病的关键事件.
- 早期发现斑块脆弱性对于预防危及生命的事件至关重要.
- 蛋白质组工具为识别新型循环生物标志物和治疗点提供了潜力.
研究的目的:
- 在过去20年中,审查omics技术在研究动脉动脉生成和斑块脆弱性的应用.
- 强调脂质蛋白质组学和血管组织蛋白质组学的作用.
- 讨论该领域的挑战和未来方向.
主要方法:
- 在人类基质 (血管细胞,组织,血,尿液) 和实验性动脉样硬化中对omics应用的审查.
- 专注于脂质蛋白组学和血管组织蛋白组学.
- 分析组织分析中的挑战,包括斑块复杂性和对照.
主要成果:
- 奥米克技术显著提高了对动脉样硬化退化途径的理解.
- 已经利用各种人类矩阵和实验模型来识别潜在的生物标志物.
- 脂质蛋白质组学和血管组织蛋白质组学因其贡献而受到重视.
结论:
- 欧米学方法,特别是脂蛋白学和血管组织蛋白学,对于解开动脉生成至关重要.
- 识别早期的斑块存在和脆弱性的生物标志物对于疾病预防至关重要.
- 解决样本分析方面的挑战将为未来的治疗策略铺平道路.
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Inflammation
53.7K
Overview
53.7K
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9


